Literature DB >> 7644296

Cyclosporin A toxicity: MRI appearance of the brain.

M T Pace1, T L Slovis, J K Kelly, S D Abella.   

Abstract

Neurotoxicity is a recognized complication with the use of Cyclosporin A (CSA) in bone marrow and organ transplantation patients. Most common symptoms are seizures and altered mental status which are usually transient. We report three cases of transient neurotoxic episodes in patients receiving CSA after a bone marrow transplant. There were reversible low-attenuation changes on CT and bright T2-weighted signal changes on MRI in the cortex and/or white matter of the cerebral hemispheres. All three patients, when given lower maintenance doses of CSA, were free of recurrent neurotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644296     DOI: 10.1007/bf02021528

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  15 in total

1.  Cyclosporine central neurotoxicity following renal transplantation. Report of a case using magnetic resonance images.

Authors:  S J Scheinman; E R Reinitz; G Petro; R A Schwartz; F S Szmalc
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

2.  Hypertension and convulsions in children receiving cyclosporin A.

Authors:  D V Joss; A J Barrett; J R Kendra; C F Lucas; S Desai
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

3.  Cyclosporin, methylprednisolone, and convulsions.

Authors:  M A Boogaerts; P Zachee; R L Verwilghen
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

4.  Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?

Authors:  K P Nordal; T Talseth; E Dahl; A Attramadal; D Albrechtsen; J Halse; E K Brodwall; A Flatmark
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

5.  MR findings in methotrexate-induced CNS abnormalities.

Authors:  F Ebner; G Ranner; I Slavc; C Urban; R Kleinert; H Radner; R Einspieler; E Justich
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

6.  Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

7.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

8.  Cerebral blindness and encephalopathy with cyclosporin A toxicity.

Authors:  A M Rubin; H Kang
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

9.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

10.  Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

Authors:  M R Lucey; J C Kolars; R M Merion; D A Campbell; M Aldrich; P B Watkins
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  2 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Enhanced survival of human-induced pluripotent stem cell transplant in parkinsonian rat brain by locally applied cyclosporine.

Authors:  Michael Sheyner; Seong-Jin Yu; Yun Wang
Journal:  Brain Circ       Date:  2019-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.